Health Care & Life Sciences » Pharmaceuticals | U-Home Group Holdings Ltd.

U-Home Group Holdings Ltd. | Income Statement

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
35,648.00
35,079.00
76,003.80
66,658.00
68,705.00
230,542
Cost of Goods Sold (COGS) incl. D&A
28,192.00
29,692.00
59,717.20
50,974.00
29,102.00
140,320
Gross Income
7,456.00
5,387.00
16,286.60
15,684.00
39,603.00
90,222
SG&A Expense
16,932.00
9,974.00
9,748.00
15,163.00
27,343.00
34,297
EBIT
13,952.00
14,464.00
6,538.70
-
12,260.00
55,925
Unusual Expense
8,709.00
3,074.00
2,000.00
45,472.00
97,886.00
38,693
Non Operating Income/Expense
36,640.00
106,175.00
16,686.60
6,122.00
1,262.00
16,225
Interest Expense
4,435.00
1,401.00
-
3,499.00
10,817.00
12,677
Pretax Income
11,961.00
94,384.00
25,517.30
49,888.00
103,561.00
98,503
Income Tax
5,559.00
32,302.00
15,208.00
14,672.00
23,817.00
25,059
Equity in Affiliates
35,352.00
27,135.00
-
-
-
8,080
Consolidated Net Income
41,754.00
89,217.00
10,309.30
35,216.00
79,744.00
81,524
Net Income
41,754.00
89,219.00
10,312.00
34,380.00
80,066.00
80,537
Net Income After Extraordinaries
41,754.00
89,219.00
10,312.00
34,380.00
80,066.00
80,537
Net Income Available to Common
41,754.00
89,219.00
10,312.00
34,380.00
80,066.00
80,537
EPS (Basic)
0.02
0.05
0.01
0.01
0.02
0.02
Basic Shares Outstanding
1,714,810.00
1,732,139.70
2,010,694.00
2,715,380.00
3,330,275.00
3,742,332
EPS (Diluted)
0.02
0.05
0.01
0.01
0.02
0.02
Diluted Shares Outstanding
1,722,874.60
1,732,598.40
2,010,694.00
2,715,380.00
3,330,275.00
3,742,332
EBITDA
13,233.00
14,371.00
9,912.00
2,623.00
13,157.00
57,088
Other Operating Expense
4,476.00
9,877.00
-
-
-
-
Non-Operating Interest Income
2,417.00
1,000.00
292.00
1,272.00
2,970.00
337
Minority Interest Expense
-
2.00
2.70
836.00
322.00
987

About U-Home Group Holdings

View Profile
Address
Unit 2906
Hong Kong
Hong Kong
Employees -
Website -
Updated 07/08/2019
Meilleure Health International Industry Group Ltd. engages in the research and sale of medicine and health care products, development of chemical and biological products, and multiple industrial investment and holdings. It operates through the following segments: Trading of Healthcare Products; Agency Service, Property Development, Propery Investment and Leasing Business, Health Care Related Business, and Corporate. The Trading of Healthcare Products segment involves trading of pharmaceutical and health care products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.